Literature DB >> 20503263

Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction.

Eric P Davidson1, Lawrence J Coppey, Nigel A Calcutt, Christine L Oltman, Mark A Yorek.   

Abstract

BACKGROUND: The objective of this study was to determine the effect of diet-induced obesity (DIO) on microvascular and neural function.
METHODS: Rats were fed a standard or high fat diet for up to 32 weeks. The following measurements were carried out: vasodilation in epineurial arterioles using videomicroscopy, endoneurial blood flow using hydrogen clearance, nerve conduction velocity using electrical stimulation, size-frequency distribution of myelinated fibres of the sciatic nerve, intraepidermal nerve fibre density using confocal microscopy and thermal nociception using the Hargreaves method.
RESULTS: Rats fed a high fat diet for 32 weeks developed sensory neuropathy, as indicated by slowing of sensory nerve conduction velocity and thermal hypoalgesia. Motor nerve conduction velocity and endoneurial blood flow were not impaired. Mean axonal diameter of myelinated fibres of the sciatic nerve was unchanged in high fat-fed rats compared with that in control. Intraepidermal nerve fibre density was significantly reduced in high fat-fed rats. Vascular relaxation to acetylcholine and calcitonin gene-related peptide was decreased and expression of neutral endopeptidase (NEP) increased in epineurial arterioles of rats fed a high fat diet. In contrast, insulin-mediated vascular relaxation was increased in epineurial arterioles. NEP activity was significantly increased in the skin of the hindpaw. Markers of oxidative stress were increased in the aorta and serum of high fat-fed rats but not in epineurial arterioles.
CONCLUSION: Chronic obesity causes microvascular and neural dysfunction. This is associated with increased expression of NEP but not oxidative stress in epineurial arterioles. NEP degrades vasoactive peptides, which may explain the decrease in microvascular function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20503263      PMCID: PMC2878284          DOI: 10.1002/dmrr.1088

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  64 in total

1.  Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers.

Authors:  MarcosA Antezana; Stephen R Sullivan; MarciaL Usui; NicoleS Gibran; MichelleL Spenny; JerrieA Larsen; JohnC Ansel; NigelW Bunnett; JohnE Olerud
Journal:  J Invest Dermatol       Date:  2002-12       Impact factor: 8.551

2.  Oxidative stress in a rat model of obesity-induced hypertension.

Authors:  A D Dobrian; M J Davies; S D Schriver; T J Lauterio; R L Prewitt
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

3.  Protection of sensory function in diabetic rats by Neotrofin.

Authors:  Nigel A Calcutt; Jason D Freshwater; Nils Hauptmann; Eve M Taylor; Andrew P Mizisin
Journal:  Eur J Pharmacol       Date:  2006-02-28       Impact factor: 4.432

Review 4.  Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways.

Authors:  Evren Caglayan; Florian Blaschke; Yasunori Takata; Willa A Hsueh
Journal:  Curr Opin Pharmacol       Date:  2005-04       Impact factor: 5.547

5.  Circulating fatty acids, non-high density lipoprotein cholesterol, and insulin-infused fat oxidation acutely influence whole body insulin sensitivity in nondiabetic men.

Authors:  A M Poynten; S K Gan; A D Kriketos; L V Campbell; D J Chisholm
Journal:  J Clin Endocrinol Metab       Date:  2004-11-23       Impact factor: 5.958

6.  Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction.

Authors:  K Terata; L J Coppey; E P Davidson; J A Dunlap; D D Gutterman; M A Yorek
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

7.  Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction.

Authors:  C L Oltman; E P Davidson; L J Coppey; T L Kleinschmidt; M A Yorek
Journal:  Diabetes Obes Metab       Date:  2008-06-16       Impact factor: 6.577

8.  Effects of the peptide HP228 on nerve disorders in diabetic rats.

Authors:  N A Calcutt; K C Dines; R M Ceseña
Journal:  Metabolism       Date:  1998-06       Impact factor: 8.694

9.  Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy.

Authors:  Irina G Obrosova; Fei Li; Omorodola I Abatan; Mark A Forsell; Katalin Komjáti; Pal Pacher; Csaba Szabó; Martin J Stevens
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

10.  Sensory nerve innervation of epineurial arterioles of the sciatic nerve containing calcitonin gene-related peptide: effect of streptozotocin-induced diabetes.

Authors:  M A Yorek; L J Coppey; J S Gellett; E P Davidson
Journal:  Exp Diabesity Res       Date:  2004 Jul-Sep
View more
  45 in total

Review 1.  Exercise as Therapy for Diabetic and Prediabetic Neuropathy.

Authors:  J Robinson Singleton; A Gordon Smith; Robin L Marcus
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

2.  Changes in corneal innervation and sensitivity and acetylcholine-mediated vascular relaxation of the posterior ciliary artery in a type 2 diabetic rat.

Authors:  Eric P Davidson; Lawrence J Coppey; Amey Holmes; Mark A Yorek
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

3.  Effect of mitoquinone (Mito-Q) on neuropathic endpoints in an obese and type 2 diabetic rat model.

Authors:  Brian Fink; Lawrence Coppey; Eric Davidson; Hanna Shevalye; Alexander Obrosov; Pratik Rajesh Chheda; Robert Kerns; William Sivitz; Mark Yorek
Journal:  Free Radic Res       Date:  2020-04-24

4.  Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications.

Authors:  Eric P Davidson; Lawrence J Coppey; Amey Holmes; Brian Dake; Mark A Yorek
Journal:  Eur J Pharmacol       Date:  2011-07-28       Impact factor: 4.432

5.  Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats.

Authors:  Christine L Oltman; Eric P Davidson; Lawrence J Coppey; Travis L Kleinschmidt; Brian Dake; Mark A Yorek
Journal:  Eur J Pharmacol       Date:  2010-10-30       Impact factor: 4.432

6.  Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice.

Authors:  Kristen A Baltgalvis; Kathy White; Wei Li; Mark D Claypool; Wayne Lang; Raniel Alcantara; Baljit K Singh; Annabelle M Friera; John McLaughlin; Derek Hansen; Kelly McCaughey; Henry Nguyen; Ira J Smith; Guillermo Godinez; Simon J Shaw; Dane Goff; Rajinder Singh; Vadim Markovtsov; Tian-Qiang Sun; Yonchu Jenkins; Gerald Uy; Yingwu Li; Alison Pan; Tarikere Gururaja; David Lau; Gary Park; Yasumichi Hitoshi; Donald G Payan; Todd M Kinsella
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-21       Impact factor: 4.733

7.  Insulin prevents aberrant mitochondrial phenotype in sensory neurons of type 1 diabetic rats.

Authors:  Mohamad-Reza Aghanoori; Darrell R Smith; Subir Roy Chowdhury; Mohammad Golam Sabbir; Nigel A Calcutt; Paul Fernyhough
Journal:  Exp Neurol       Date:  2017-08-10       Impact factor: 5.330

8.  Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress.

Authors:  Sergey Lupachyk; Pierre Watcho; Nailia Hasanova; Ulrich Julius; Irina G Obrosova
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

Review 9.  The Potential Role of Fatty Acids in Treating Diabetic Neuropathy.

Authors:  Mark A Yorek
Journal:  Curr Diab Rep       Date:  2018-08-25       Impact factor: 4.810

Review 10.  Alternatives to the Streptozotocin-Diabetic Rodent.

Authors:  M A Yorek
Journal:  Int Rev Neurobiol       Date:  2016-03-28       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.